- Home
- WMPN vs ECOR Comparison
WMPN vs ECOR Comparison
Compare WMPN & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WMPN
- ECOR
- Stock Information
- Founded
- WMPN 1870
- ECOR 2005
- Country
- WMPN United States
- ECOR United States
- Employees
- WMPN N/A
- ECOR N/A
- Industry
- WMPN Savings Institutions
- ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- WMPN Finance
- ECOR Health Care
- Exchange
- WMPN Nasdaq
- ECOR Nasdaq
- Market Cap
- WMPN 104.2M
- ECOR 111.3M
- IPO Year
- WMPN N/A
- ECOR 2018
- Fundamental
- Price
- WMPN $12.55
- ECOR $16.32
- Analyst Decision
- WMPN Buy
- ECOR Strong Buy
- Analyst Count
- WMPN 1
- ECOR 1
- Target Price
- WMPN $14.00
- ECOR $25.00
- AVG Volume (30 Days)
- WMPN 14.4K
- ECOR 121.6K
- Earning Date
- WMPN 01-15-2025
- ECOR 03-12-2025
- Dividend Yield
- WMPN 0.99%
- ECOR N/A
- EPS Growth
- WMPN N/A
- ECOR N/A
- EPS
- WMPN N/A
- ECOR N/A
- Revenue
- WMPN $20,363,000.00
- ECOR $23,327,000.00
- Revenue This Year
- WMPN N/A
- ECOR $59.81
- Revenue Next Year
- WMPN N/A
- ECOR $38.49
- P/E Ratio
- WMPN N/A
- ECOR N/A
- Revenue Growth
- WMPN N/A
- ECOR 74.10
- 52 Week Low
- WMPN $10.80
- ECOR $5.32
- 52 Week High
- WMPN $13.87
- ECOR $18.67
- Technical
- Relative Strength Index (RSI)
- WMPN 59.49
- ECOR 54.47
- Support Level
- WMPN $11.18
- ECOR $14.04
- Resistance Level
- WMPN $13.08
- ECOR $16.24
- Average True Range (ATR)
- WMPN 0.32
- ECOR 1.08
- MACD
- WMPN 0.12
- ECOR -0.27
- Stochastic Oscillator
- WMPN 72.11
- ECOR 42.52
About WMPN William Penn Bancorporation
William Penn Bancorporation operates as an independent community financial services provider. The bank offers traditional banking and related financial services to individual, business, and government customers. Through its branch and automated teller machine network, the bank offers a full array of commercial and retail financial services, including; the taking of time, savings, and demand deposits; the making of commercial, consumer, and mortgage loans; and the providing of other financial services.
About ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.